Phase 3
Completed N=16
Insulin Delivery Using Microneedles in Type 1 Diabetes
Source: ClinicalTrials.gov NCT00837512 ↗Enrolled (actual)
16
Serious AEs
0.0%
Results posted
Jan 2014
Primary outcomePrimary: Onset Time (Tmax) — 30; 52 Minutes
Summary
The goal of this study is to determine if microneedles can effectively and painlessly deliver insulin to children and young adults with type 1 diabetes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Onset Time (Tmax) |
30; 52 | — |
Eligibility Criteria
Inclusion Criteria
- ≥ 8 years of age
- 2 grades behind age-appropriate grade)
- Pregnant or breast-feeding (if female).
Data sourced from ClinicalTrials.gov (NCT00837512). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.